Microcystin-LR activates the ERK1/2 kinases and stimulates the proliferation of the monkey kidney-derived cell line Vero-E6

Toxicology in Vitro

Volumn 24, Issue 6, 2010, Pages 1689-1695

  Dias, E ^a,b   Matos, P ^a   Pereira, P ^a   Batoreu M C C ^b   Silva, M J ^a   Jordan, P ^a  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

Author keywords

ERK1 2; Kidney; Microcystin LR; Tumour promotion

Indexed keywords

MICROCYSTIN LR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; KIDNEY CELL; KIDNEY TUMOR; MICROCYSTIS AERUGINOSA; MONKEY; NONHUMAN; TUMOR PROMOTION; VERO CELL;

ANIMALS; BACTERIAL TOXINS; CARCINOGENS; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MICROCYSTINS; MICROCYSTIS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; VERO CELLS;

ANIMALIA; CYANOBACTERIA;

EID: 77956172500     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2010.05.018     Document Type: Article

References (53)

1. Alverca E., Andrade M., Dias E., Sam-Bento F., Batoéru M.C.C., Jordan P., Silva M.J., Pereira P. Morphological and ultrastructural effects of microcystin-LR from Microcystis aeruginosa extract on a kidney cell line. Toxicon 2009, 54:283-294.
2. Boaru D.A., Dragoş N., Schirmer K. Microcystin-LR induced cellular effects in mammalian and fish primary hepatocyte cultures and cell lines: a comparative study. Toxicology 2006, 218:134-148.
3. Botha N., Van de Venter M., Downing T.G., Shepard E.G., Gehringer E.G. The effect of intraperitoneally administered microcystin-LR on the gastrointestinal tract of Balb/c mice. Toxicon 2004, 43:251-254.
4. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature 2001, 410:37-40.
5. Chen Y.M., Lee T.H., Lee S.J., Huang H.B., Huang R., Chou H.N. Comparison of protein phosphatase inhibition activities and mouse toxicities of microcystins. Toxicon 2006, 47:742-746.
6. Codd G.A. Cyanobacterial toxins, the perception of water quality, and the prioritisation of eutrophication control. Ecol. Eng. 2000, 16:51-60.
7. Codd G.A., Morrison L.F., Metcalf J.S. Cyanobacterial toxins. Risk management for health protection. Toxicol. Appl. Pharmacol. 2005, 203:264-272.
8. Codogno P., Meijer A.J. Autophagy and signaling: their role in cell survival and death. Cell Death Different. 2005, 12:1509-1518.
9. Dhillon A.S., Hagan S., Rath O., Kolch W. MAP kinase signalling pathways in cancer. Oncogene 2007, 26:3279-3290.
10. Dias E., Andrade M., Alverca E., Pereira P., Batoréu M.C.C., Jordan P., Silva M.J. Comparative study of the cytotoxic effect of microcystin-LR and purified extracts from Microcystis aeruginosa on a kidney cell line. Toxicon 2009, 53:487-495.
11. Ding X.S., Li X.Y., Duan H.Y., Chung I.K., Lee J.A. Toxic effects of microcystis cell extracts on the reproductive system of male mice. Toxicon 2006, 48:973-979.
12. Duy T.N., Lam P.K.S., Shaw G.R., Connell D.W. Toxicology and risk assessment of freshwater cyanobacterial (blue-green algae) toxins in water. Rev. Environ. Contam. Toxicol. 2000, 163:113-186.
13. Eskelinen E.L., Saftig P. Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochem. Biophys. Acta 2009, 1793:664-673.
14. Falconer I.R. Tumour promotion and liver injury caused by oral consumption of cyanobacteria. Environ. Toxicol. Water Qual. 1991, 6:177-184.
15. Falconer I.R., Yeung D.S. Cytoskeletal changes in hepatocytes induced by microcystis toxins and their relation to hyperphosphorylation of cell proteins. Chem. Biol. Interact. 1992, 81:181-196.
16. Fang J.L., Richardson B.C. The MAPK signalling pathways and colorectal cancer. Lancet Oncol. 2005, 6:322-327.
17. Fischer W.L., Altheimer S., Cattori V., Meier P.J., Dietrich D.R., Hagenbuch B. Organic anion transporting polypeptides expressed in liver and brain mediate uptake of microcystin. Toxicol. Appl. Pharmacol. 2005, 203:257-263.
18. Funari E., Testai E. Human health risk assessment related to cyanotoxin exposure. Crit. Rev. Toxicol. 2008, 38:97-125.
19. Gaudin J., Huet S., Jarry G., Fessard V. In vivo DNA damage induced by the cyanotoxin microcystin-LR: comparison of intra-peritoneal and oral administration by use of the comet assay. Mutat. Res. 2008, 652:65-71.
20. Gehringer M.M. Microcystin-LR and okadaic acid-induced cellular effects: a dualistic response. FEBS Lett. 2004, 557:1-8.
21. Gilley R., March H.N., Cook S.J. ERK1/2, but not ERK5, is necessary and sufficient for phosphorylation and activation of c-Fos. Cell. Signal. 2009, 21:969-977.
22. Hagenbuch B., Meier P.J. The superfamily of organic anion transporting polypeptides. Biochim. Biophys. Acta 2003, 1609:1-18.
23. Humpage A.R., Hardy S.J., Moore E.J., Froscio S.M., Falconer I.R. Microcystins (cyanobacterial toxins) in drinking water enhance the growth of aberrant crypt foci in the mouse colon. J. Toxicol. Environ. Health A 2000, 61:155-165.
24. IARC, 2006. Cyanobacterial peptide toxins. Available from: http://monographs.iarc.fr/ENG/Meetings/94-cyanobacteria.pdf.
25. ISO 20179, 2005. Water quality - determination of microcystins - method using solid phase extraction (SPE) and high performance liquid chromatography (HPLC) with ultraviolet (UV) detection.
26. Ito E., Takai A., Kondo F., Masui H., Imanishi S., Harada K.I. Comparison of protein phosphatase inhibitory activity and apparent toxicity of microcystins and related compounds. Toxicon 2002, 40:1017-1025.
27. Junttila M.R., Li S.P., Westermarck J. Phosphatase-mediated crosstalk between MAPK signalling pathways in the regulation of cell survival. FASEB J. 2008, 22:954-965.
28. Komatsu M., Furukawa T., Ikeda R., Takumi S., Nong Q., Aoyama K., Akiyama S.I., Keppler D., Takeuchi T. Involvement of mitogen-activated protein kinase signalling pathways in microcystins-LR-induced apoptosis after its selective uptake mediated by OATP1B1 and OATP1B3. Toxicol. Sci. 2007, 97:407-416.
29. Li H., Xie P., Li G., Hao L., Xiong Q. In vivo study on the effects of microcystin extracts on the expression profiles of proto-oncogenes (c-fos, c-jun and c-myc) in liver, kidney and testis of male Wistar rats injected i.v. with toxins. Toxicon 2009, 53:169-175.
30. Maidana M., Carlis V., Galhardi F.G., Yunes J.S., Geracitano L.A., Monserrat J.M., Barros D.M. Effects of microcystins over short- and long-term memory and oxidative stress generation in hippocampus of rats. Chem.-Biol. Interact. 2006, 159:223-234.
31. Meijer A.J., Codogno P. Regulation and role of autophagy in mammalian cells. Int. J. Biochem. Cell Biol. 2004, 36:2445-2462.
32. Meloche S., Pouysségur J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 2007, 26:3227-3239.
33. Milutinović A., Sedmark B., Horvat-ŽnidarŠić I., Šuput D. Renal injuries induced by chronic intoxication with microcystins. Cell. Mol. Biol. Lett. 2002, 7:139-141.
34. Milutinović A., Živin M., Zorc-Plesković R., Sedmark B., Šuput D. Nephrotoxic effects of chronic administration of microcystins-LR and -YR. Toxicon 2003, 42:281-288.
35. Moniz S., Peter P. Emerging roles for WNK kinases in cancer. Cell. Mol. Life Sci. 2010, 67:1265-1276.
36. Moniz S., Veríssimo F., Matos P., Brazão R., Silva E., Kotevelets L., Chastre E., Gespach C., Jordan P. Protein kinase WNK2 inhibits cell proliferation by negatively modulating the activation of MEK1/ERK1/2. Oncogene 2007, 26:6071-6081.
37. Nishiwaki-Matsushima R., Ohta T., Nishiwaki S., Suganuma M., Kohyama K., Ishikawa T., Carmichael W.W., Fujiki H. Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR. J. Cancer Res. Clin. Oncol. 1992, 118:420-424.
38. Nobre A.C.L., Jorge M.C.M., Menezes D.B., Fonteles M.C., Monteiro H.S.A. Effects of microcystin-LR in isolated perfused rat kidney. Brazil. J. Med. Biol. Res. 1999, 32:985-988.
39. Ogier-Nenis E., Pattingre S., Benna J.E., Codogno P. Erk1/2-dependent phosphorylation of Gα-interacting protein stimulates its GTPase accelerating activity and autophagy in human colon cancer cells. J. Biol. Chem. 2000, 275:39090-39095.
40. Pattingre S., Bauvy C., Codogno P. Amino acids interfere with the Erk1/2-dependent control of macroautophagy by controlling the activation of Raf-1 in human colon cancer HT-29 cells. J. Biol. Chem. 2003, 278:16667-16674.
41. Philips H.J. Dye exclusion tests for cell viability. Tissue Culture: Methods and Applications 1973, 406-408. Academic Press, NY. P.F. Kruse, M.K. Patterson (Eds.).
42. Robinson N.A., Pace J.G., Matson C.F., Miura G.A., Lawrence W.B. Tissue distribution, excretion and hepatic biotransformation of microcystin-LR in mice. J. Pharmacol. Exp. Ther. 1990, 256:176-182.
43. Soares M., Cagido V.R., Ferraro R.B., Meyer-Fernandes J.R., Rocco P.R.M., Zin W.A., Azevedo S.M.F.O. Effects of microcystin-LR on mouse lungs. Toxicon 2007, 50:330-338.
44. Turatti E., Neves A.C., Magalhães M.H.C.G., Sousa S.O.M. Assessment of c-Jun, c-Fos and cyclin D1 in premalignant and malignant oral lesions. J. Oral Sci. 2005, 47:71-76.
45. Ueno Y., Nagata S., Tsutsumi T., Hasegawa A., Watanabe M.F., Park H.D., Chen G.C., Chen G., Yu S.Z. Detection of microcystins, a blue-green algal hepatotoxins, in drinking water sampled in Haimen and Fusui, endemic areas of primary liver cancer in China, by highly sensitive immunoassay. Carcinogenesis 1996, 17:1317-1321.
46. Valério E., Chambel L., Faria N., Paulino S., Pereira P., Tenreiro R. Molecular identification, typing and traceability of cyanobacteria from freshwater reservoirs. Microbiology 2009, 155:642-656.
47. Valério E., et al. Multiplex PCR for detection of microcystins-producing cyanobacteria from freshwater samples. Environ. Toxicol. 2009, 10.1002/Tox.20502.
48. Van Apeldoorn M.E., van Egmond H.P., Speijers G.J.A., Bakker G.J.I. Toxins of cyanobacteria. Mol. Nutr. Food Res. 2007, 51:7-60.
49. WHO, 2008. Guidelines for Drinking Water Quality, third ed. Incorporating the First and Second Addenda, vol. 1, Recommendations. World Health Organization, Geneva.
50. Yoshizawa I., Matsushima R., Watanabe M.F., Harada H., Ichihara A., Carmichael W.W., Fujiki H. Inhibition of protein phosphatases by microcystis and nodularin associated with hepatotoxicity. J. Cancer Res. Clin. Oncol. 1990, 116:609-614.
51. Yu S.Z. Primary prevention of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 1995, 10:674-682.
52. Zhou L., Yu H., Chen K. Relationship between microcystin in drinking water and colorectal cancer. Biomed. Environ. Sci. 2002, 15:166-171.
53. Zhu Y., Zhong X., Zheng S., Ge Z., Du Q., Zhang S. Transformation of immortalized colorectal crypt cells by microcystin involving constitutive activation of Akt and MAPK cascade. Carcinogenesis 2005, 26:1207-1214.